Protocol Ledger

NCT04967989 · Phase III · RECRUITING

Clarifying the Optimal Application of SLT Therapy Trial

Interventional Phase III clinical trial protocol NCT04967989 sponsored by University of Pittsburgh in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-09-07 Enrollment: 790 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04967989
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)790 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04967989
Protocol FieldVerified Registry Value
NCT IdentifierNCT04967989
Consolidated Lead SponsorUniversity of Pittsburgh
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment790 participants (ESTIMATED)
Registered Start Date2021-09-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI